| Product Code: ETC7555431 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import of therapeutic vaccines into India saw a significant shift in 2024, with top exporters being the USA, Denmark, China, Sweden, and South Korea. The market concentration, as measured by the Herfindahl-Hirschman Index (HHI), escalated from moderate in 2023 to high in 2024. The compound annual growth rate (CAGR) for the period of 2020-2024 was -22.7%, indicating a decline in market size, with a steep negative growth rate of -49.05% from 2023 to 2024. This data suggests a dynamic landscape in the therapeutic vaccines market in India, with changing trends in imports and market concentration.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Therapeutic Vaccines Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Therapeutic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 India Therapeutic Vaccines Market - Industry Life Cycle |
3.4 India Therapeutic Vaccines Market - Porter's Five Forces |
3.5 India Therapeutic Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Therapeutic Vaccines Market Revenues & Volume Share, By Therapeutic Vaccines, 2021 & 2031F |
4 India Therapeutic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in India |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Growing focus on preventive healthcare |
4.2.4 Technological advancements in vaccine development |
4.3 Market Restraints |
4.3.1 Cost constraints for developing and accessing therapeutic vaccines |
4.3.2 Regulatory challenges and approval processes |
4.3.3 Limited awareness and acceptance of therapeutic vaccines among the population |
5 India Therapeutic Vaccines Market Trends |
6 India Therapeutic Vaccines Market, By Types |
6.1 India Therapeutic Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Therapeutic Vaccines Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Therapeutic Vaccines Market Revenues & Volume, By Peptide Therapeutic Vaccine, 2021- 2031F |
6.1.4 India Therapeutic Vaccines Market Revenues & Volume, By Cell Therapeutic Vaccine, 2021- 2031F |
6.1.5 India Therapeutic Vaccines Market Revenues & Volume, By Nucleic Acid Therapeutic Vaccine, 2021- 2031F |
6.2 India Therapeutic Vaccines Market, By Therapeutic Vaccines |
6.2.1 Overview and Analysis |
6.2.2 India Therapeutic Vaccines Market Revenues & Volume, By Oncotherapy, 2021- 2031F |
6.2.3 India Therapeutic Vaccines Market Revenues & Volume, By Hepatitis B, 2021- 2031F |
6.2.4 India Therapeutic Vaccines Market Revenues & Volume, By Tuberculosis, 2021- 2031F |
6.2.5 India Therapeutic Vaccines Market Revenues & Volume, By Herpes Simplex Virus, 2021- 2031F |
6.2.6 India Therapeutic Vaccines Market Revenues & Volume, By Others, 2021- 2031F |
7 India Therapeutic Vaccines Market Import-Export Trade Statistics |
7.1 India Therapeutic Vaccines Market Export to Major Countries |
7.2 India Therapeutic Vaccines Market Imports from Major Countries |
8 India Therapeutic Vaccines Market Key Performance Indicators |
8.1 Number of vaccines included in national immunization programs |
8.2 Investment in research and development for therapeutic vaccines |
8.3 Number of partnerships and collaborations for vaccine development |
8.4 Immunization coverage rates for target diseases |
8.5 Number of new vaccine approvals by regulatory authorities |
9 India Therapeutic Vaccines Market - Opportunity Assessment |
9.1 India Therapeutic Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Therapeutic Vaccines Market Opportunity Assessment, By Therapeutic Vaccines, 2021 & 2031F |
10 India Therapeutic Vaccines Market - Competitive Landscape |
10.1 India Therapeutic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 India Therapeutic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here